The new four-in-one "quad" pill for HIV treatment offers hope for those patients beset by the pill regiment necessary to combat the disease, according to a study published in the Lancet this week.
Managing HIV requires a strict regimen of several pills daily. Researchers hope the quad pill, called such for containing four combined drugs, will make treatments easier and more effective.
"Patient adherence to medication is vital, especially for patients with HIV, where missed doses can quickly lead to the virus becoming resistant to medication," study co-author Paul Sax said.
"Our results provide an additional highly potent, well-tolerated treatment option and highlight the simplicity of treatment resulting from combining several antiretrovirals in a single pill."
The quad pill received backing from an FDA advisory panel in early May. On August 27, the agency will decide whether to approve the drug for sale in the United States.
by RTT Staff Writer
For comments and feedback: email@example.com